Ionis Pharmaceuticals Inc
IONS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000874015
In the last 90 days, Ionis Pharmaceuticals Inc insiders filed 1 open-market purchase and 4 sales; 515 institutions reported holding it in 13F filings for Q2 2026, worth $14.3B in total; ARK Invest is the only superinvestor holding it.
Q2 2021 vs. Q1 2021
How the institutions holding Ionis Pharmaceuticals Inc changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Of which not filed for Q2 2021 | Q2 2021 | Change |
|---|---|---|---|---|
| Holders | 365 | 3 | 338 | −24 |
| Shares | 123.5M | 1.71M | 124.4M | +2.62M (+2.2%) |
| Value | $5.55B | $76.8M | $4.96B | −$516.2M (−9.4%) |
3 institutions that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (51)
Institutions that held Ionis Pharmaceuticals Inc at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (75)
Institutions that held Ionis Pharmaceuticals Inc at the end of Q1 2021 and filed for Q2 2021 without it.
Not filed for Q2 2021 yet (3)
Institutions that held Ionis Pharmaceuticals Inc at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Waddell & Reed Financial Inc | 1,613,947 | $72.6M |
| Amundi Asset Management US, Inc. | 82,126 | $3.69M |
| Bokf, NA | 11,710 | $526.0K |